| Year |
Citation |
Score |
| 2015 |
Boyd MJ, Bandarage UK, Bennett H, Byrn RR, Davies I, Gu W, Jacobs M, Ledeboer MW, Ledford B, Leeman JR, Perola E, Wang T, Bennani Y, Clark MP, Charifson PS. Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25: 1990-4. PMID 25827523 DOI: 10.1016/j.bmcl.2015.03.013 |
0.428 |
|
| 2015 |
Abdelhamed AM, Zhang SX, Watkins T, Morgan MA, Wu F, Buckner RJ, Fuller DD, Davis TE, Salimnia H, Fairfax MR, Lephart PR, Poulter MD, Regi SB, Jacobs MR. Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles. Journal of Clinical Microbiology. 53: 1672-6. PMID 25762766 DOI: 10.1128/JCM.00549-15 |
0.352 |
|
| 2014 |
Clark MP, Ledeboer MW, Davies I, Byrn RA, Jones SM, Perola E, Tsai A, Jacobs M, Nti-Addae K, Bandarage UK, Boyd MJ, Bethiel RS, Court JJ, Deng H, Duffy JP, et al. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. Journal of Medicinal Chemistry. 57: 6668-78. PMID 25019388 DOI: 10.1021/jm5007275 |
0.449 |
|
| Show low-probability matches. |